AzTrials
AzTrials

MultimorbidityNCT04955600

Digital Technology in the Home of Elderly Patients With Multimorbidity

An observational study of Multimorbidity, run by Sormland County Council, Sweden at 1 site in Sweden.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

In this study, the objective is to evaluate available technology designed to support self-care at home of elderly patients with multimorbidity. Of people who are 85 years or older, about 60% have two or more chronic diseases. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Multimorbidity
What is being tested?
Implementation Study
How many people
25 participants
Where
1 siteSweden
Study dates
1 Mar 2021to 31 Dec 2023
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: The study aims to include all patients, family members and healthcare personal who is involved in the process of implementation of digital technology.

Who may be able to join

  • All patients admitted in the care team and their family members who will have digital technology placed in their home will be asked to participate.
  • All healthcare personal in the care team will be asked to participate

Who cannot join

  • 0

Trial locations and contacts

1 site in 1 country.

Sweden1 site
  • Care team in Region of Sörmland

    Eskilstuna, SE-63188

Other trials in Sweden

About this study

Official title: Introducing Technology in the Home of Elderly Patients With Multimorbidity, a Hybrid Effectiveness Implementation Study

In this study, the objective is to evaluate available technology designed to support self-care at home of elderly patients with multimorbidity. Of people who are 85 years or older, about 60% have two or more chronic diseases. The symptom burden is extensive, and periods of deterioration often lead to hospitalizations and early readmissions to hospital. A contributing factor for the high consumption of care is that many patients find it difficult to identify signs of deterioration and in time take appropriate action. Technology placed in patients' home are becoming common and have shown to increase quality of life and reduce the need for in-hospital care but few tools are used in regular care.

The investigators want to see which effect technologies placed at home has on; healthcare consumption, self-care, depression, well-being and activity level. Further, the implementation process from both patients, relatives and healthcare personals perspective will be studied using a hybrid design, which makes it possible to study both barriers and facilitators of the implementation and efficacy of the technology.

In phase one participants will be recruited from a care team where an established collaboration between region and municipality has been developed. In phase two, inclusion takes place in an entire municipality without a previously established collaboration. The goal is to increase patients and family members wellbeing, health and functional ability while maintaining or reducing healthcare costs.

Read the detailed description

PURPOSE AND AIMS In this study, the objective is to evaluate available digital technology with remote symptom monitoring designed to support self-care at home of elderly patients with multimorbidity. There are a lot of technology with the possibility to remotely monitor signs and symptoms placed in patients' home available. This technology have been shown to increase quality of life, experiences of security and reduce the need for in-hospital care, but few tools are implemented in routine care of elderly with multimorbidity and extensive needs of coordinated health and community care. Limited collaboration and lack of joint care goals between the different care providers are known barriers of implementation of digital technology with remote symptom monitoring.

The overall aims of the project are:

  1. To describe the implementation process of digital technology in two different care settings from both patients, family members, and healthcare professional's perspective.
  2. To evaluate the feasibility of digital technology for remote symptom monitoring and digital consultations with the caregiver in the home of elderly patients with multimorbidity.
  3. To examine the effectiveness of the technology.

Specific research questions the study is set to answer:

  1. What effects does the use of digital technology for remote symptom monitoring have on elderly patients with multimorbidity's healthcare consumption, self-care management, depression, experience of control over the disease, well-being and activity level?
  2. How do patients and informal caregivers perceive that the use of digital technology at home affects the ability to manage the patient's health situation?
  3. How do physicians, nurses and assistant nurses experience the use of remote monitoring in their daily work?
  4. Which are the barriers to and facilitators for implementation of digital technology?
  5. Does digital technology reduce the risk of hospitalisation and healthcare costs in elderly patients with multimorbidity?

The study has a hybrid design, which means a double focus: both the implementation process and the clinical outcomes are studied simultaneously through a mixed data collection with both quantitative and qualitative parts. The implementation process will be based on The Quality Implementation Framework.

Phase 1; During winter 2021-22 the implementation process of digital technology with remote symptom monitoring with adaptation and preparation in the care team will begin. The team needs to develop a structure for handling the incoming patient data and develop action plans on how to act in case of symptoms and signs of deterioration.

The technology, OPTILOGG PLUS, will be place in patients' home.It consists of a tablet with personalized sensors, such as weighing scale, blood pressure, oxygenation and activity meters based on the patient's individual needs. The technology also includes a platform for digital consultation.

The patient performs measurements at home every morning and sends data to the receiving station installed in the care teams' premises where the staff access the patient's data via secure login.The main purpose of the technology is to enhance the patients' self-care behaviour, and coach them to contact the healthcare provider if and when self-care is not enough to prevent deterioration. Also the caregiver can initiate a virtual home visit or a physical home visit if they observe signs of deterioration not recognised by the patient.

Conditions
Multimorbidity
Being tested
Implementation Study
Keywords
telemonitoring, distance monitoring, feasibility, implementation, elderly

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Implementation StudyOther

    Implementation of digital technology in two different care settings from both patients, informal caregivers, and healthcare professional's perspective.

Study groups in NCT04955600
Study groupRoleWhat they receive
elderly patients with multimorbidity, relatives, health care personalThe care team consists of four nurses, two of whom are employed by the region and two by the municipality, 20 municipally employed assistant nurses and one physician. Other professions associated with the team are psychologist, dietitian, pharmacist, counsellor, physiotherapist, occupational therapist, and family consultants. All participants in the team will be invited to participate in the study. The technology will be place in 20-25 patients' home and patients and family members will be invited to participate in the study. Self-care education will be given to the patients and family members according to the middle-range theory of self-care of chronic illness.
Receives: Other: Implementation Study

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Effectiveness of digital technology

    Healthcare consumption will be performed via regions healthcare database.

    Measured: December 2021-December 2022

  2. Implementation process

    Healthcare professionals will be asked about potential barriers and facilitators for implementation of the technology, problems associated with the implementation, potential modifications that could be made to maximize implementation, potential implementation strategies, skills or training necessary for healthcare professionals to work with the technology.

    Measured: April 2021-December 2021

Secondary outcomes (5)
  1. Experience of digital technology

    Experience of the technology will be measured by a self-designed survey. Care and nursing staff from both the region and the municipality will is asked to answer a self-constructed questionnaire regarding experiences of the implementation of digital technology,

    Measured: December 2021-December 2022

  2. Anxiety and depression

    In-depth surveys for patients; Hospital Anxiety and Depression Scale

    Measured: December 2021-December 2022

  3. Perceived control

    Control Attitude Scale

    Measured: December 2021-December 2022

  4. Well-being

    WHO Welfare Index

    Measured: December 2021-December 2022

  5. Physical activity

    Frändin Grimby's activity scale

    Measured: December 2021-December 2022

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted9 Jul 2021
  2. Study start1 Mar 2021
  3. Primary completion31 Dec 2023
  4. Study completion31 Dec 2023

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Family based
Time perspective
Prospective
Enrolment
25 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04955600
Sponsor's protocol ID
Maria Liljeroos
Status last verified
Apr 2024
First submitted
16 Jun 2021
Last updated
4 Apr 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Liljeroos M, Akerberg A, Arkkukangas M. Older Adults and Healthcare Professional's Experiences of Telemonitoring in Primary Home-Based Care in Sweden: A Feasibility Study. Clin Interv Aging. 2026 Apr 25;21:595091. doi: 10.2147/CIA.S595091. eCollection 2026.

    PubMed 42064100
  • Liljeroos M, Arkkukangas M, Stromberg A. The long-term effect of an m-health tool on self-care in patients with heart failure: a pre-post interventional study with a mixed-method analysis. Eur J Cardiovasc Nurs. 2024 Jul 19;23(5):470-477. doi: 10.1093/eurjcn/zvad107.

    PubMed 38165027

Questions about this trial

What is this clinical trial studying?

An observational study of Multimorbidity, run by Sormland County Council, Sweden at 1 site in Sweden.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 4 Apr 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Sweden. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Effectiveness of digital technology (time frame: December 2021-December 2022). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT04955600, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 4 Apr 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in